Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy
about
Immunotherapy in human colorectal cancer: Challenges and prospectiveγδ T cells in cancer immunotherapyHepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronateNecroptosis of Dendritic Cells Promotes Activation of γδ T Cells.Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cellsImmunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung CancerLow-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma.Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.CD56 in the Immune System: More Than a Marker for Cytotoxicity?Gamma-delta (γδ) T cells: friend or foe in cancer development?Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.Trial watch: Dendritic cell-based anticancer immunotherapy.Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.Oxaliplatin-induced changes in microbiota, TLR4+ cells and enhanced HMGB1 expression in the murine colon.
P2860
Q28068788-04355A4E-1E2E-4168-93DD-89BE9BDB3F08Q28068988-D85D747D-399F-42B3-9095-E46B20CB4F36Q36734208-05FA1C84-79E7-41C4-99FB-2907AC68F933Q37212146-A6B414C4-9E54-43DD-A6B5-0A76E1B4FB13Q37294760-389ACB46-CB6A-4251-8409-CF334B639207Q37606871-B55A9A14-9C8B-4DCE-A7BE-F78B129B73A4Q37701514-B9096AFC-EBA2-4A8A-A2D8-FA8AB3B8F39EQ38787725-7A1D98E6-2CF6-4B3E-9D5F-2F75D255D4D4Q39014899-EF8B8391-2B3F-4F9D-87DD-FF0EDA2A439AQ39138688-D559C8A4-D24C-4EFC-932F-67D85FF1F8F4Q40101148-17E91177-C8A6-46BD-8DC2-8163290A6011Q47742552-34BB127C-6CDC-41C8-B770-BBF22FA7D43FQ52716912-64D24238-9494-4EF5-BD4C-728DAA276C16Q53109846-5028B029-0984-41CF-8D12-8B12C8ABA8B1Q54974328-9BE7801C-6FC9-4C24-8781-2380F2A72806Q55174561-882AEDDF-D245-4230-9D40-083F932C5C92Q55198257-28A727D5-AA59-4233-8DD6-2C58C283B18D
P2860
Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@ast
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@en
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@nl
type
label
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@ast
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@en
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@nl
prefLabel
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@ast
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@en
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@nl
P2093
P2860
P3181
P1433
P1476
Empowering gamma delta T cells ...... ritic cell-based immunotherapy
@en
P2093
Heleen H Van Acker
Sébastien Anguille
Viggo F Van Tendeloo
P2860
P304
P3181
P356
10.1080/2162402X.2015.1021538
P50
P577
2015-04-01T00:00:00Z